List of works - Josep M Llibre

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

scientific article published in July 2009

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

scientific article

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

scientific article (publication date: 2012)

Baseline CD4+ T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients ⬇️

scientific article published on January 1, 2011

Bronchiolitis Obliterans Organizing Pneumonia Associated with Acute Mycoplasma pneumoniae Infection ⬇️

scientific article published on December 1, 1997

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

scientific article

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

article

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir

scientific article published on January 1, 2010

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

scientific article published on 14 May 2013

Effect of efavirenz versus nevirapine in antiretroviral-naive individuals in the HIV-CAUSAL Collaboration Cohort ⬇️

scientific article published on October 23, 2012

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals

scientific article published on 27 January 2014

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

scientific article

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.

scientific article

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Encephalitis with multiple space occupying lesions in a patient with human immunodeficiency virus type 1 infection ⬇️

scientific article published on February 15, 2011

Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab

scientific article published on 01 December 2019

Hepatitis C Virus Infection and Progression of Infection Due to Human Immunodeficiency Virus ⬇️

scientific article published on January 1, 1993

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

article

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens ⬇️

scientific article published on March 19, 2012

Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study

scientific article published on 04 September 2019

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

scientific article

Short Communication: High Effectiveness of Etravirine in Routine Clinical Practice in Treatment-Experienced HIV Type 1-Infected Patients

article

The Role of Inactive Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Salvage Therapy for Drug-Resistant HIV-1 Infection in the Era of New Classes and New Generation Antiretrovirals

article

The changing face of HIV/AIDS in treated patients

scientific article published on July 2009

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

scientific article published on 13 April 2015

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

scientific article

List of works by Josep M Llibre

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

Baseline CD4+ T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients ⬇️

Bronchiolitis Obliterans Organizing Pneumonia Associated with Acute Mycoplasma pneumoniae Infection ⬇️

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

Effect of efavirenz versus nevirapine in antiretroviral-naive individuals in the HIV-CAUSAL Collaboration Cohort ⬇️

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Encephalitis with multiple space occupying lesions in a patient with human immunodeficiency virus type 1 infection ⬇️

Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab

Hepatitis C Virus Infection and Progression of Infection Due to Human Immunodeficiency Virus ⬇️

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens ⬇️

Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

Short Communication: High Effectiveness of Etravirine in Routine Clinical Practice in Treatment-Experienced HIV Type 1-Infected Patients

The Role of Inactive Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Salvage Therapy for Drug-Resistant HIV-1 Infection in the Era of New Classes and New Generation Antiretrovirals

The changing face of HIV/AIDS in treated patients

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.